- All sections
- C - Chemistrymetallurgy
- C40B - Combinatorial chemistrylibraries, e.g. chemical libraries
- C40B 30/04 - Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
Patent holdings for IPC class C40B 30/04
Total number of patents in this class: 2244
10-year publication summary
114
|
98
|
103
|
115
|
127
|
90
|
81
|
77
|
75
|
57
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Prognosys Biosciences, Inc. | 104 |
52 |
The Regents of the University of California | 20087 |
51 |
President and Fellows of Harvard College | 5998 |
38 |
University Health Network | 1051 |
30 |
The Board of Trustees of the Leland Stanford Junior University | 6462 |
27 |
Massachusetts Institute of Technology | 10110 |
23 |
The Johns Hopkins University | 5714 |
21 |
10X Genomics, Inc. | 1252 |
21 |
Bio-Rad Laboratories, Inc. | 1617 |
21 |
Bioatla, Inc. | 108 |
20 |
The University of British Columbia | 1509 |
17 |
Chugai Seiyaku Kabushiki Kaisha | 1368 |
16 |
Arizona Board of Regents on behalf of Arizona State University | 2663 |
15 |
Celera Corporation | 77 |
15 |
The Broad Institute, Inc. | 1839 |
14 |
Janssen Biotech, Inc. | 1559 |
14 |
Vibrant Holdings, LLC | 71 |
14 |
Bristol-myers Squibb Company | 4855 |
13 |
Genentech, Inc. | 4001 |
13 |
Illumina, Inc. | 3373 |
13 |
Other owners | 1796 |